Home > Financial Ratios > MANGALAM DRUGS AND ORGANICS

MANGALAM DRUGS AND ORGANICS
EBIT Growth

    Back to All Ratios
MANGALAM DRUGS AND ORGANICS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MANGALAM DRUGS AND ORGANICS
Please provide your vote to see the results

MANGALAM DRUGS AND ORGANICS Last 5 Year EBIT Growth History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EBIT Growth(%) -61.52-20.37193.25472.52-92.93

What is the latest EBIT Growth ratio of MANGALAM DRUGS AND ORGANICS ?

The latest EBIT Growth ratio of MANGALAM DRUGS AND ORGANICS is -61.52 based on Mar2023 Standalone results.
Year EBIT Growth
Mar2023-61.52
Mar2022-20.37
Mar2021193.25
Mar2020472.52
Mar2019-92.93

How is EBIT Growth of MANGALAM DRUGS AND ORGANICS Trending?

Years EBIT Growth % Change
Mar2023 -61.52
Negative
Mar2022 -20.37
Negative
Mar2021 193.25
-59.10
Mar2020 472.52
Positive
Mar2019 -92.93 -

Other Financial Ratios of MANGALAM DRUGS AND ORGANICS


Compare EBIT Growth ratio of peers of MANGALAM DRUGS AND ORGANICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS ₹161.6 Cr 1.5% 10.4% -10.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,315.0 Cr -0.1% -6.3% 53.5% Stock Analytics
CIPLA ₹114,614.0 Cr 1% -5% 53.3% Stock Analytics
DIVIS LABORATORIES ₹105,233.0 Cr 3.2% 15.3% 23.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,900.0 Cr 1.1% 2.2% 26% Stock Analytics
ZYDUS LIFESCIENCES ₹99,426.0 Cr 3.9% -1.7% 85.2% Stock Analytics


MANGALAM DRUGS AND ORGANICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS

1.5%

10.4%

-10.9%

SENSEX

1%

2.2%

23.7%


You may also like the below Video Courses